WallStSmart
SGHT

Sight Sciences Inc

NASDAQ: SGHT · HEALTHCARE · MEDICAL DEVICES

$4.09
+3.02% today

Updated 2026-04-30

Market cap
$237.20M
P/E ratio
P/S ratio
3.07x
EPS (TTM)
$-0.74
Dividend yield
52W range
$3 – $9
Volume
0.4M

Sight Sciences Inc (SGHT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$7.53M$23.35M$27.64M$48.96M$71.33M$81.06M$79.87M$77.36M
Revenue growth (YoY)+210.1%+18.4%+77.1%+45.7%+13.6%-1.5%-3.1%
Cost of revenue$2.34M$6.54M$9.21M$8.61M$12.36M$11.88M$11.58M$10.70M
Gross profit$5.19M$16.80M$18.43M$40.35M$58.97M$69.17M$68.28M$66.67M
Gross margin69.0%72.0%66.7%82.4%82.7%85.3%85.5%86.2%
R&D$5.43M$8.12M$8.87M$15.63M$22.86M$17.56M$17.99M$14.61M
SG&A$13.06M$30.92M$40.95M$74.09M$117.47M$106.79M$99.43M$89.16M
Operating income$-14.30M$-24.04M$-32.19M$-51.48M$-83.95M$-57.27M$-50.53M$-37.10M
Operating margin-189.9%-103.0%-116.5%-105.2%-117.7%-70.7%-63.3%-48.0%
EBITDA$-14.23M$-23.47M$-31.68M$-57.20M$-80.48M$-49.41M$-45.90M$-36.61M
EBITDA margin-189.0%-100.5%-114.6%-116.8%-112.8%-61.0%-57.5%-47.3%
EBIT$-14.30M$-23.90M$-32.23M$-58.41M$-81.73M$-50.03M$-46.61M$-37.10M
Interest expense$0.00$1.96M$2.40M$4.37M$4.47M$5.41M$4.66M$5.14M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-14.29M$-25.87M$-34.69M$-62.96M$-86.24M$-55.55M$-51.51M$-38.43M
Net income growth (YoY)-81.0%-34.1%-81.5%-37.0%+35.6%+7.3%+25.4%
Profit margin-189.8%-110.8%-125.5%-128.6%-120.9%-68.5%-64.5%-49.7%